Search

Your search keyword '"Das, Rituparna"' showing total 772 results

Search Constraints

Start Over You searched for: Author "Das, Rituparna" Remove constraint Author: "Das, Rituparna"
772 results on '"Das, Rituparna"'

Search Results

1. Enhanced strong-field ionization and fragmentation of methanol using non-commensurate fields

4. Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

5. Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases

9. Review of Implementation of ESG Norms in India

11. Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results

13. Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial

17. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

19. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

24. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial

26. Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients.

27. Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults.

28. Application of Measure of Non-compactness for the Existence of Solutions of an Infinite System of Differential Equations in the Sequence Spaces of Convergent and Bounded Series

32. Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines

33. Long-term safety and efficacy of COVE study open-label and booster phases

35. Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial

43. Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines.

45. Interim report of the reactogenicity and immunogenicity of SARS-CoV-2 XBB-containing vaccines

47. Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

48. Age and sex specific variations in body composition in Indian urban Bengali Hindu children, adolescents and young adults aged 7–21 years

Catalog

Books, media, physical & digital resources